2019 BIO International Convention
BIO International Convention 2019 3 to 6 June 2019 / Philadelphia / USA Madiha Derouazi attending
Entries by Jean-François Mayol
European Life Sciences CEO Forum
European Life Sciences CEO Forum 2019 25 & 26 February 2019 / Zurich / Switzerland Madiha Derouazi attending
AMAL Therapeutics finalises €29 million (CHF 33.2 million) Series B round
Geneva, Switzerland – 12 September 2018 – AMAL Therapeutics (AMAL), the Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, today announces that it has completed the second closing of its Series B financing round. The second and final tranche of €21.2 million (CHF 24.2 million) brings the total round to just over €29 million (CHF […]
Amal Therapeutics featured in September edition of BioPharma Dealmaker (Springer-Nature)
Geneva, Switzerland – 19 September 2018 – We are pleased to announce that AMAL Therapeutics is featured in the September edition of BioPharma Dealmakers (Nature Research), outlining the promise of protein-based therapeutics cancer vaccine in oncology. View PDF
ESMO Geneva 13-16 Dec 2018
ESMO Immuno Oncology – Geneva 2018 13-16 December / Geneva / Switzerland Amal Therapeutics Team attending
Biofit 4-5 December 2018
BioFIT 2018 4-5 December / Lille / France Madiha Derouazi speaking
World Immunotherapy Congress 29-31 October2018
World Immunotherapy Congress 2018 29-31 October / Basel / Switzerland Madiha Derouazi speaking
ESMO Munich 19-23 Oct 2018
ESMO – Munich 2018 19-23 October / Munich / Germany Madiha Derouazi attending
IPO Day 13 June 2018
IPO Day Lausanne 2018 13 June / Lausanne / Switzerland Madiha Derouazi attending
Cell and Gene Therapy 26 Sept 2018
Cell and Gene Therapy 2018 26 September / Zurich / Switzerland Jean-François Mayol attending
Amal Therapeutics SA
c/o Fondation pour Recherches Médicales
64 av. de la Roseraie
1205 Geneva
Switzerland
